Search

everythinglearnresearchcommunity

for

Search:↓

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Nivolumab can cause hair loss as a rare side effect.

Thyroid receptor β can help develop new drugs to treat hair loss.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Mutations in the Vitamin D receptor gene can cause hair loss similar to mutations in the Hairless gene.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Pili torti is a rare condition where hair is twisted and breaks easily, often linked to genetic disorders or other health issues.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Cyclosporine may cause hair loss, so patients need monitoring.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

Male pattern baldness is a common hair loss in men caused by genetics and hormones, with treatments including drugs, hair transplants, and hair loss products.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.